8-31081132-C-T

Variant summary

Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_000553.6(WRN):​c.1105C>T​(p.Arg369*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000255 in 1,613,510 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00031 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00025 ( 0 hom. )

Consequence

WRN
NM_000553.6 stop_gained

Scores

1
3
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:11O:1

Conservation

PhyloP100: 0.0680
Variant links:
Genes affected
WRN (HGNC:12791): (WRN RecQ like helicase) This gene encodes a member of the RecQ subfamily of DNA helicase proteins. The encoded nuclear protein is important in the maintenance of genome stability and plays a role in DNA repair, replication, transcription and telomere maintenance. This protein contains a N-terminal 3' to 5' exonuclease domain, an ATP-dependent helicase domain and RQC (RecQ helicase conserved region) domain in its central region, and a C-terminal HRDC (helicase RNase D C-terminal) domain and nuclear localization signal. Defects in this gene are the cause of Werner syndrome, an autosomal recessive disorder characterized by accelerated aging and an elevated risk for certain cancers. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-31081132-C-T is Pathogenic according to our data. Variant chr8-31081132-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 5449.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-31081132-C-T is described in Lovd as [Pathogenic]. Variant chr8-31081132-C-T is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
WRNNM_000553.6 linkc.1105C>T p.Arg369* stop_gained Exon 9 of 35 ENST00000298139.7 NP_000544.2 Q14191

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
WRNENST00000298139.7 linkc.1105C>T p.Arg369* stop_gained Exon 9 of 35 1 NM_000553.6 ENSP00000298139.5 Q14191
WRNENST00000651642.1 linkc.400C>T p.Arg134* stop_gained Exon 3 of 4 ENSP00000498779.1 A0A494C0Y6
WRNENST00000650667.1 linkn.*719C>T non_coding_transcript_exon_variant Exon 8 of 34 ENSP00000498593.1 A0A494C0M3
WRNENST00000650667.1 linkn.*719C>T 3_prime_UTR_variant Exon 8 of 34 ENSP00000498593.1 A0A494C0M3

Frequencies

GnomAD3 genomes
AF:
0.000310
AC:
47
AN:
151766
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000968
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00112
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000952
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000324
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.000171
AC:
43
AN:
250884
Hom.:
0
AF XY:
0.000162
AC XY:
22
AN XY:
135562
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.000895
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000185
Gnomad NFE exome
AF:
0.000221
Gnomad OTH exome
AF:
0.000491
GnomAD4 exome
AF:
0.000249
AC:
364
AN:
1461744
Hom.:
0
Cov.:
32
AF XY:
0.000245
AC XY:
178
AN XY:
727168
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.0000671
Gnomad4 ASJ exome
AF:
0.00130
Gnomad4 EAS exome
AF:
0.000202
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.000206
Gnomad4 NFE exome
AF:
0.000261
Gnomad4 OTH exome
AF:
0.000248
GnomAD4 genome
AF:
0.000310
AC:
47
AN:
151766
Hom.:
0
Cov.:
32
AF XY:
0.000297
AC XY:
22
AN XY:
74066
show subpopulations
Gnomad4 AFR
AF:
0.0000968
Gnomad4 AMR
AF:
0.00112
Gnomad4 ASJ
AF:
0.000577
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.0000952
Gnomad4 NFE
AF:
0.000324
Gnomad4 OTH
AF:
0.000479
Alfa
AF:
0.000388
Hom.:
0
Bravo
AF:
0.000370
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000189
AC:
23
EpiCase
AF:
0.000164
EpiControl
AF:
0.000356

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:11Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Werner syndrome Pathogenic:7Other:1
-
GeneReviews
Significance: not provided
Review Status: no classification provided
Collection Method: literature only

Most common pathogenic variant worldwide; accounts for 20%-25% of pathogenic variants in the European and Japanese populations. -

Mar 30, 2024
Baylor Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 11, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change creates a premature translational stop signal (p.Arg369*) in the WRN gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in WRN are known to be pathogenic (PMID: 16673358). This variant is present in population databases (rs17847577, gnomAD 0.09%). This premature translational stop signal has been observed in individual(s) with Werner syndrome (PMID: 8968742, 9225981, 16786514, 25182132). This variant is also known as 1336C>T and Arg368*. ClinVar contains an entry for this variant (Variation ID: 5449). For these reasons, this variant has been classified as Pathogenic. -

Oct 04, 2018
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The p.Arg369X variant in WRN has been reported in >20 homozygous or compound het erozygous individuals with Werner syndrome and has been reported to be the most common variant in Caucasian patients with Werner syndrome (Oshima 1996, Matsumot o 1997, Uhrhammer 2006, Huang 2006). This variant has been identified in 0.02% ( 52/276580) of chromosomes from the general population by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org/) and is reported in ClinVar (Variation ID: 5449). This nonsense variant leads to a premature termination cod on at position 369, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the WRN gene is an established disease mechani sm in individuals with Werner syndrome. In summary, this variant meets criteria to be classified as pathogenic for Werner syndrome in an autosomal recessive man ner based upon presence in affected individuals and predicted impact to the prot ein. ACMG/AMP Criteria applied: PVS1, PM3_VeryStrong. -

Sep 02, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: WRN c.1105C>T (p.Arg369X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 0.00017 in 250884 control chromosomes. This frequency is not significantly higher than expected for a pathogenic variant in WRN causing Werner Syndrome (0.00017 vs 0.0025), allowing no conclusion about variant significance. c.1105C>T has been reported in the literature in multiple individuals affected with Werner Syndrome. These data indicate that the variant is very likely to be associated with disease. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -

Feb 10, 2023
Revvity Omics, Revvity
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 01, 1997
OMIM
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: literature only

- -

May 13, 2024
Fulgent Genetics, Fulgent Genetics
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Pathogenic:3
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 01, 2022
GeneDx
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 31921681, 9225981, 25525159, 8968742, 27153395, 29753700, 16673358, 25182132, 25390333, 16786514, 29625052, 26689913, 31263571, 31589614, 32041611, 33077847, 33087645) -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Pathogenic
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Medulloblastoma Pathogenic:1
May 10, 2018
St. Jude Molecular Pathology, St. Jude Children's Research Hospital
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This is a nonsene alteration in which a C is replaced by a T at coding nucleotide 1105 and is predicted to change an Arginine to a premature stop codon at amino acid codon 369. Classification criteria: PVS1, PM2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Pathogenic
0.27
CADD
Pathogenic
35
DANN
Uncertain
0.99
Eigen
Uncertain
0.20
Eigen_PC
Benign
-0.11
FATHMM_MKL
Benign
0.045
N
Vest4
0.55
GERP RS
2.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs17847577; hg19: chr8-30938648; COSMIC: COSV53296548; API